Science, Innovation, and Longevity with Jose Luis Ricón Fernández de la Puente
Jul 26, 2020•3 hr 40 min
Episode description
Jose Luis Ricón Fernández de la Puente (@ArtirKel) joins Erik on this episode. He is currently at Twitter and is a researcher in several areas including the science of longevity.
They discuss:
- How science funding works currently and how it would work if he was redesigning the system.
- Whether progress in science is slowing down.
- His thoughts on GDP and how we measure innovation.
- Whether the FDA is too restrictive or too permissive.
- Healthcare costs in the USA, treatments with marginal benefits, and how a publicly-funded system triages patients.
- How to fight aging and improve longevity.
- The cultural problem with longevity research.
- Challenges and opportunities in education and potential solutions.
- His production function and why he puts bounties on his papers for others to find mistakes.
Thanks for listening — if you like what you hear, please review us on your favorite podcast platform.
Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.
They discuss:
- How science funding works currently and how it would work if he was redesigning the system.
- Whether progress in science is slowing down.
- His thoughts on GDP and how we measure innovation.
- Whether the FDA is too restrictive or too permissive.
- Healthcare costs in the USA, treatments with marginal benefits, and how a publicly-funded system triages patients.
- How to fight aging and improve longevity.
- The cultural problem with longevity research.
- Challenges and opportunities in education and potential solutions.
- His production function and why he puts bounties on his papers for others to find mistakes.
Thanks for listening — if you like what you hear, please review us on your favorite podcast platform.
Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.